IE 11 is not supported. For an optimal experience visit our site on another browser.

Pain Therapeutics to Present at Jefferies Healthcare Conference

AUSTIN, Texas, June 2, 2011 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management will present at Jefferies 2011 Global Healthcare Conference in New York City on Thursday, June 9th at 10:00 a.m. Eastern Time.
/ Source: GlobeNewswire

AUSTIN, Texas, June 2, 2011 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management will present at Jefferies 2011 Global Healthcare Conference in New York City on Thursday, June 9th at 10:00 a.m. Eastern Time.

A live audio webcast of the presentation will be available on the company's website homepage at . A replay of the audio webcast will continue to be available on the website for one month.

About Pain Therapeutics, Inc.

Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. We conceived, developed, trademarked and partnered REMOXY®, a unique abuse-resistant formulation of oxycodone. A New Drug Application for REMOXY is on file with the FDA, with a PDUFA date of June 23, 2011. Pfizer, Inc. is our commercial partner for REMOXY and three other pain medications (abuse-resistant formulations of hydromorphone, hydrocodone and oxymorphone). In addition, we are developing a novel radio-labeled monoclonal antibody to treat metastatic melanoma, a deadly form of skin cancer. We are also working on a new treatment for patients with hemophilia, a genetic disorder in which patients are unable to stop bleeding. For more information, please visit .

CONTACT: Judy Ishida Administrative Manager Pain Therapeutics, Inc. IR@paintrials.com 650-645-1924